Compare NNBR & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNBR | TLPH |
|---|---|---|
| Founded | 1980 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.8M | 37.9M |
| IPO Year | 1996 | 2010 |
| Metric | NNBR | TLPH |
|---|---|---|
| Price | $2.04 | $0.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 495.5K | 187.3K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.60 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $770,657,000.00 | $2,151,000.00 |
| Revenue This Year | $8.60 | N/A |
| Revenue Next Year | $6.30 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $0.38 |
| 52 Week High | $2.63 | $1.57 |
| Indicator | NNBR | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 73.23 | 53.19 |
| Support Level | $1.85 | $0.73 |
| Resistance Level | $2.29 | $0.88 |
| Average True Range (ATR) | 0.16 | 0.06 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 74.20 | 82.50 |
NN Inc is a diversified industrial company that combines engineering and production capabilities with materials science expertise to design and manufacture high-precision components and solutions. The company operates through two segments: Mobile Solutions, which generates maximum revenue and focuses on the automotive, general industrial, and medical end markets, manufacturing tight-tolerance components used in battery electric, hybrid electric, and internal combustion engine vehicles, braking, transmissions, fuel systems, HVAC, and diesel systems; and Power Solutions, which focuses on the electrical, general industrial, automotive, medical, and aerospace and defense end markets and manufactures high-precision metal components, assemblies, contact assemblies, and precision stampings.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.